Skip to content
Screener

LENZ Therapeutics, Inc. LENZ Q4 2025 Annual earnings

Reported March 24, 2026 · Before market open

Revenue$1.6MMiss by $1.5M
EPS-$1.16Miss by $0.25
Revenue estimate$3.1M
EPS estimate-$0.91

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$4.5M
EPS estimate-$1.02

FAQ

When did LENZ Therapeutics, Inc. report Q4 2025 earnings?
LENZ Therapeutics, Inc. (LENZ) reported Q4 2025 earnings on March 24, 2026 before market open.
What were LENZ Therapeutics, Inc.'s Q4 2025 revenue and EPS?
LENZ Therapeutics, Inc. reported revenue of $1.6M and eps of $-1.16 for Q4 2025.
Did LENZ Therapeutics, Inc. beat estimates in Q4 2025?
Revenue missed the consensus estimate of $3.1M by $1.5M. EPS missed the consensus estimate of $-0.91 by $0.25.
How did LENZ Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 152.2% from $-0.46.
Where can I find LENZ Therapeutics, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001815776-26-000008) and the 10-K periodic report (0001815776-26-000011) directly on SEC EDGAR. The filing index links above go to sec.gov.